The global Generic Injectables Market is projected to surpass US$ 307.7 billion by 2031, expanding at a robust compound annual growth rate (CAGR) of 12.3% from 2021 to 2031. Generic injectables, bioequivalent alternatives to branded injectable drugs, are used in oncology, infectious diseases, and cardiovascular conditions, offering cost-effective treatment options. The market's growth is driven...